EMP 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 10
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004315880013 -
GGREM
508026080211607 -
Código de barras
7891317052997
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- EMPAGLIFLOZINA
- Embalagem
- 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 10
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "EMP 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 10",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891317052997"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508026080211607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "EMP",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 10",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "66.20",
"icms-12": "75.23",
"icms-17": "79.76",
"icms-18": "80.73",
"icms-19": "81.73",
"icms-20": "82.75",
"icms-21": "83.80",
"icms-22": "84.87",
"icms-23": "85.97",
"icms-17.5": "80.24",
"icms-19.5": "82.24",
"icms-20.5": "83.27",
"icms-22.5": "85.42",
"icms-12-alc": "67.17",
"icms-17-alc": "71.21",
"icms-18-alc": "72.08",
"icms-19-alc": "72.97",
"icms-20-alc": "73.88",
"icms-21-alc": "74.82",
"icms-22-alc": "75.78",
"icms-23-alc": "76.76",
"withoutTaxes": "59.11",
"icms-17.5-alc": "71.65",
"icms-19.5-alc": "73.43",
"icms-20.5-alc": "74.35",
"icms-22.5-alc": "76.27"
},
"pisCofinsList": "Negativa",
"substanceText": "EMPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "88.80",
"icms-12": "100.92",
"icms-17": "107.00",
"icms-18": "108.30",
"icms-19": "109.64",
"icms-20": "111.01",
"icms-21": "112.41",
"icms-22": "113.85",
"icms-23": "115.33",
"icms-17.5": "107.64",
"icms-19.5": "110.32",
"icms-20.5": "111.70",
"icms-22.5": "114.59",
"icms-12-alc": "92.86",
"icms-17-alc": "98.44",
"icms-18-alc": "99.65",
"icms-19-alc": "100.88",
"icms-20-alc": "102.13",
"icms-21-alc": "103.43",
"icms-22-alc": "104.76",
"icms-23-alc": "106.12",
"withoutTaxes": "81.71",
"icms-17.5-alc": "99.05",
"icms-19.5-alc": "101.51",
"icms-20.5-alc": "102.78",
"icms-22.5-alc": "105.44"
},
"invalidBarcodes": [],
"activeSubstances": [
"EMPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004315880013",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508026080211607"